
One Drug Can Appear in Four Databases and Produce Four Different Counts
by Brandon Burley
Topic hub
TRP reporting and conversations on emerging synthetic opioids, toxicology, forensic detection, surveillance preparedness and public-safety response.
3 articles · 6 podcast episodes

by Brandon Burley

by Brandon Burley

by Brandon Burley
TRP Newsroom / Main Feed
by Brandon Burley and The Redemption Project Federal detections of a new synthetic opioid show why drug markets do not spread state by state the way most people assume. Federal laboratory detections of a new synthetic opioid known as N-propionitrile chlorphine are raising broader questions about how emerging drug compounds move through U.S. supply networks. The compound was first confirmed by a DEA laboratory in 2024, with later detections reported in states including Texas, California, Illinois, Missouri, and Tennessee. New Mexico reports no confirmed identifications to date. State officials say the compound has not been detected in seized materials there, but that existing laboratory workflows would be capable of identifying it if it appeared. Forensic experts note that synthetic opioids do not spread state by state in a predictable pattern. They move through trafficking networks, wholesale relationships, and supply hubs, often appearing in one region while remaining absent in nearby states. That means the more important question is not whether a compound has reached a state yet. It is whether surveillance systems are prepared to recognize it when it does. Drug markets often follow relationships, logistics, and supply chains rather than geography. A compound may surface repeatedly in one region while remaining absent nearby for months or longer. That is why laboratory readiness often matters more than assumptions based on maps. I am a retired detective and criminal justice / government educator based in Tennessee. I am a commentary write for Tennessee Lookout and a weekly columnist with Knox TN Today . My work examines public policy, public safety systems and civic responsibility. My reporting and commentary have also appeared in Governing , The Arizona Capitol Times , South Florida Sun Sentinel , Police1 , among other state and regional outlets. Get full access to The Redemption Project Newsroom at newsroom.theredemptionproject.news/subscribe
Open episode →TRP Newsroom / Main Feed
by Brandon Burley and The Redemption Project Jefferson County officials say cychlorphine has not been detected locally, but the larger issue is how forensic laboratories decide what they are prepared to see. Jefferson County forensic officials say a newly engineered synthetic opioid known as cychlorphine has not been detected in local postmortem toxicology casework. Officials say the compound is not currently part of routine toxicology panels, although internal communications have already been issued to maintain awareness of the drug. Cychlorphine was first confirmed in a U.S. seizure by a DEA forensic laboratory in 2024, with later detections reported in states including Texas, California, Illinois, Missouri, and Tennessee. In Tennessee, forensic officials have linked the compound to multiple overdose deaths under investigation, including at least one fatal case where it was the only opioid identified. Laboratory experts say detection often depends on whether a compound is included in routine screening or whether expanded testing is required. For now, Jefferson County says no local detection has been confirmed. That does not necessarily mean laboratories are unconcerned. It means awareness often begins before routine identification becomes necessary. As synthetic opioid chemistry continues to evolve, toxicology readiness increasingly depends on whether laboratory systems are prepared before compounds appear regularly enough to demand broader response. For forensic systems, the question is rarely only whether a compound is present. It is whether laboratories are positioned to recognize it when it arrives. I am a retired detective and criminal justice / government educator based in Tennessee. I am a commentary write for Tennessee Lookout and a weekly columnist with Knox TN Today . My work examines public policy, public safety systems and civic responsibility. My reporting and commentary have also appeared in Governing , The Arizona Capitol Times , South Florida Sun Sentinel , Police1 , among other state and regional outlets. Get full access to The Redemption Project Newsroom at newsroom.theredemptionproject.news/subscribe
Open episode →TRP Newsroom / Main Feed
by Brandon Burley and The Redemption Project European forensic systems are increasingly identifying synthetic opioids before those substances become fully visible in national overdose statistics, giving health authorities earlier warning as chemical markets evolve. Europe’s drug monitoring systems are increasingly relying on forensic laboratories to identify new synthetic opioids before those drugs appear clearly in national overdose statistics. One emerging compound, cychlorphine, has already been detected through laboratory and early warning systems in multiple jurisdictions, including Germany and the United Kingdom. The broader challenge is that synthetic opioid markets are evolving faster than many public reporting systems were designed to move. Through the European Union Early Warning System, forensic laboratories can report newly identified substances before they are widely reflected in mortality data, giving health agencies and policymakers an earlier signal that a new drug may be entering circulation. German authorities have already confirmed cychlorphine in seized-drug investigations and moved to regulate it under laws designed for rapid response to emerging synthetic substances. The larger question now is whether forensic detection can continue moving fast enough as synthetic opioid chemistry becomes more complex. Across much of Europe, laboratory alerts often arrive before mortality systems fully reflect emerging compounds. That makes forensic detection not simply a technical process, but an increasingly important part of public health readiness. I am a retired detective and criminal justice / government educator based in Tennessee. I am a commentary write for Tennessee Lookout and a weekly columnist with Knox TN Today . My work examines public policy, public safety systems and civic responsibility. My reporting and commentary have also appeared in Governing , The Arizona Capitol Times , South Florida Sun Sentinel , Police1 , among other state and regional outlets. Get full access to The Redemption Project Newsroom at newsroom.theredemptionproject.news/subscribe
Open episode →TRP Newsroom / Main Feed
by Brandon Burley and The Redemption Project As newer synthetic opioids appear, responders are again asking how consistently naloxone behaves across changing compounds. The key point remains: naloxone still matters, but chemistry rarely stays static for long. I am a retired detective and criminal justice / government educator based in Tennessee. I am a commentary write for Tennessee Lookout and a weekly columnist with Knox TN Today . My work examines public policy, public safety systems and civic responsibility. My reporting and commentary have also appeared in Governing , The Arizona Capitol Times , South Florida Sun Sentinel , Police1 , among other state and regional outlets. Get full access to The Redemption Project Newsroom at newsroom.theredemptionproject.news/subscribe
Open episode →TRP Newsroom / Main Feed
by Brandon Burley and The Redemption Project A newly emerging synthetic opioid identified in Tennessee, Canada, and parts of Europe is highlighting a larger forensic challenge: surveillance systems often only detect what laboratories are already built to recognize. A new synthetic opioid is now forcing a bigger question across multiple countries: how often do new drugs spread before public systems fully catch them? The compound is called cychlorphine. It has already appeared in overdose investigations, forensic laboratories, and seized drug supplies in places including Tennessee, Canada, and parts of Europe. In Tennessee, forensic officials have linked it to multiple deaths under investigation, and the drug has been described as roughly ten times more potent than fentanyl. But the larger issue is not just the drug itself. Many overdose dashboards only show what laboratories are already built to detect. If a new compound is not part of routine testing, it can circulate long before official numbers fully reflect what is happening. That means chemistry can move faster than surveillance. Across multiple jurisdictions, cychlorphine has already shown how differently detection systems move depending on forensic design. In Canada, federal laboratory systems identified the compound and incorporated it into routine screening after validation through Health Canada’s Drug Analysis Service. In parts of Europe, early warning systems allowed laboratories to report detections before mortality data fully reflected the substance. In the United States, forensic identification often depends on state and regional laboratory workflows, which means detection can vary by jurisdiction even when seized drug material appears elsewhere. That creates a practical gap. A compound may already exist inside supply chains while public dashboards remain largely silent. Forensic laboratories often see chemical change first. Public systems usually catch up later. As synthetic opioid chemistry continues evolving, the central question is no longer only how dangerous a new compound may be, but how quickly institutions designed for detection can recognize what has changed. In that environment, surveillance is no longer only a reporting function. It is part of public health readiness. I am a retired detective and criminal justice / government educator based in Tennessee. I am a commentary write for Tennessee Lookout and a weekly columnist with Knox TN Today . My work examines public policy, public safety systems and civic responsibility. My reporting and commentary have also appeared in Governing , The Arizona Capitol Times , South Florida Sun Sentinel , Police1 , among other state and regional outlets. Get full access to The Redemption Project Newsroom at newsroom.theredemptionproject.news/subscribe
Open episode →TRP Newsroom / Main Feed
19 deaths tied to a newer synthetic #opioid One thing the public rarely sees: forensic labs often encounter new chemistry long before public warning systems catch up. The science usually arrives before the headlines. Get full access to The Redemption Project Newsroom at newsroom.theredemptionproject.news/subscribe
Open episode →